ライフサイエンスコーパス: be approved by

1 is prospective population-based cohort study was approved by a dedicated ethics committee overseen by

2 written informed consent to a protocol that was approved by a local research ethics board and Health

3 is prospective population-based cohort study was approved by a medical ethics committee overseen by t

4 Materials and Methods The study was approved by a research ethics committee, and partici

5 The specific recommendations were approved by all members of the task force and then

6 terials and Methods This retrospective study was approved by an ethics review board, and the requirem

7 two-center retrospective observational study was approved by an institutional ethics committee, and t

8 iduals had died and had brain autopsies that were approved by board-certified neuropathologists.

9 small-molecule P2Y receptor antagonists have been approved by drug/medicines agencies.

10 A number of injectable hydrogels are approved by FDA as surgery sealants, tissue adhesive

11 It has also been approved by FDA for various orphan diseases for exp

12 rge of KCC-1, KCC-1-NH(2) and KCC-1-NH(2)-FA were approved by field emission scanning electron micros

13 the specific capturing of the nanoparticles were approved by FR-negative HEK 293 normal cells as FR-

14 tested in clinical trials, and none of them are approved by health agencies.

15 Materials and Methods The study was approved by institutional animal and human studies c

16 Materials and Methods The study was approved by institutional review and commpliant with

17 IPAA-compliant prospective multicenter study was approved by institutional review boards with written

18 These guidelines have been approved by most radiological societies, although t

19 The CREST-2 Registry (C2R) was approved by National Institute of Neurological Disor

20 60 drugs approved by the FDA (2010-2014), 40 were approved by OHOP.

21 Materials and Methods This prospective study was approved by our ethics committee, and written inform

22 ility and Accountability Act-compliant study was approved by our institutional review board with a wa

23 nonalcoholic fatty liver disease (NAFLD) has been approved by regulatory agencies.

24 plazomicin, and meropenem-vaborbactam) have been approved by regulatory authorities based on non-inf

25 sitron emission tomographic (PET) images has been approved by regulatory authorities for clinical use

26 aptan, a vasopressin 2 receptor blocker, has been approved by regulatory authorities in many countrie

27 tor (GLP-1R) agonists reduce food intake and are approved by the Food and Drug Administration for the

28 estrogen receptor-positive breast cancer and are approved by the U.S. Food and Drug Administration (F

29 l devices often undergo modifications, which are approved by the US Food and Drug Administration (FDA

30 Both treatments are approved by the US Food and Drug Administration (FDA

31 nce slow inactivation of sodium channels and are approved by the US Food and Drug Administration for

32 targeted by 69 compounds (of which, 29 drugs are approved by the US Food and Drug Administration, 12

33 Currently, no NASH-specific therapies are approved by the US Food and Drug Administration.

34 pies for SCD - hydroxyurea and L-glutamine - are approved by the US Food and Drug Administration.

35 phase III clinical trials and is expected to be approved by the U.S.

36 ereby increases full-length SMN protein, has been approved by the FDA and EMA for SMA therapy.

37 Four PARP inhibitors have been approved by the FDA as cancer therapeutics, yet a p

38 to date, less than two-dozen biomarkers have been approved by the FDA for clinical use.

39 noclonal antibody against complement C5, has been approved by the FDA for refractory MG on the basis

40 conjunction with an oral antidepressant, has been approved by the FDA for treating treatment-resistan

41 ook is a list of all drug products that have been approved by the FDA for use in veterinary medicine.

42 over 100 small-molecule oncology drugs have been approved by the FDA.

43 molecule chemokine receptor antagonists have been approved by the FDA.

44 ns characterized with potent inhibitors have been approved by the Food and Drug Administration (FDA)

45 han 30 small-molecule kinase inhibitors have been approved by the Food and Drug Administration (FDA)

46 ense oligonucleotide drugs that have already been approved by the Food and Drug Administration for ta

47 It has recently been approved by the Food and Drug Administration for th

48 It has recently been approved by the Food and Drug Administration for th

49 s recognized as an immunosuppressant and has been approved by the Food and Drug Administration to tre

50 Abeta-targeted agents have been approved by the Food and Drug Administration, with

51 d and abbreviated new drug applications have been approved by the Food and Drug Administration.

52 However, no drugs have been approved by the Food and Drug Administration.

53 s.The Health Workers Cohort Study (HWCS) has been approved by the Institutional Review Board of the M

54 This protocol has been approved by the International Centre for Diarrhoeal

55 date, about 20 PLGA-based formulations have been approved by the U.S.

56 , dalbavancin, and oritavancin have recently been approved by the U.S. Food and Drug Administration (

57 Only about two dozen formulations have been approved by the U.S. Food and Drug Administration d

58 In addition, resin microspheres have been approved by the U.S. Food and Drug Administration f

59 nvasive brain stimulation treatment that has been approved by the U.S. Food and Drug Administration f

60 Omalizumab, an anti-IgE mAb, has recently been approved by the US Food and Drug Administration (FD

61 androgen receptor modulators, which have not been approved by the US Food and Drug Administration (FD

62 ive drugs with new mechanisms of action have been approved by the US Food and Drug Administration for

63 Five medications have been approved by the US Food and Drug Administration for

64 e >100 clinical trials, only 2 new drugs had been approved by the US Food and Drug Administration for

65 agents containing EPA+DHA or EPA alone have been approved by the US Food and Drug Administration for

66 uation, three different PARP inhibitors have been approved by the US Food and Drug Administration sin

67 agitis (EoE), as of yet, no single agent has been approved by the US Food and Drug Administration to

68 The list of kinase inhibitors that have been approved by the US Food and Drug Administration was

69 ry 2020, no treatment for food allergies had been approved by the US Food and Drug Administration.

70 ures, and the decline in the number of drugs being approved by the US Food and Drug Administration ov

71 Nanoliposomal irinotecan is approved by the FDA for gemcitabine-refractory metast

72 Tocilizumab (anti-IL-6R) is approved by the Food and Drug Administration for trea

73 Use of saw palmetto is approved by the German Commission E, and several clin

74 Sorafenib is approved by the US Food and Drug Administration for m

75 e AACR SPGA Committee and the ASCO CaPC) and was approved by the AACR Boards of Directors on August 6

76 The study was approved by the animal care and use committee and wa

77 Materials and Methods The study was approved by the animal care committee.

78 Materials and Methods This study was approved by the animal care committee.

79 oup developed this position statement, which was approved by the ASHG Board in March 2017.

80 oup developed this position statement, which was approved by the ASHG Board in November 2018.

81 Each treatment was approved by the clinical ethics committee.

82 49226 was defined as 0.06 to 0.5 mug/ml and was approved by the CLSI Subcommittee on Antimicrobial S

83 After external review, a final draft was approved by the Committee for the Governance of Peri

84 The study was approved by the Committee for the Protection of Huma

85 ed from all patients, and the study protocol was approved by the committee on human research.

86 The study was approved by the Dutch Minister of Health, Welfare an

87 d Methods Design and execution of this study was approved by the Ethical Committee of Institute for R

88 The study was approved by the ethical committee of the University

89 terials and Methods This retrospective study was approved by the ethical review board, and the need t

90 The retrospective study was approved by the ethics board and did not require inf

91 The study was approved by the ethics committee for studies in huma

92 Trial registry The study protocol was approved by the Ethics Committee of Qom University o

93 Materials and Methods This prospective study was approved by the ethics committee of the University H

94 This study was approved by the ethics committee, and all participan

95 Materials and Methods This two-part study was approved by the ethics committee, and written consen

96 This retrospective case-control study was approved by the ethics committee, which waived the n

97 Materials and Methods This prospective study was approved by the ethics review board, and informed co

98 Cabozantinib was approved by the European Medicines Agency and the Fe

99 a new intranasal formulation of desmopressin was approved by the FDA in 2017.

100 Flexible BLC was approved by the FDA in 2018 for use in the surveilla

101 ranscatheter aortic valve replacement (TAVR) was approved by the Food and Drug Administration (FDA) i

102 Desmopressin was approved by the Food and Drug Administration (FDA) i

103 gher avidity variant of CTLA4Ig (abatacept), was approved by the Food and Drug Administration for pro

104 Axicabtagene ciloleucel (axi-cel) was approved by the Food and Drug Administration for rel

105 Duvelisib was approved by the Food and Drug Administration for rel

106 semisynthetic pleuromutilin antibiotic that was approved by the Food and Drug Administration for the

107 a second-generation antiandrogenic drug that was approved by the Food and Drug Administration in 2012

108 Materials and Methods The protocol was approved by the French Ethics Committee for Animal E

109 Materials and Methods The study was approved by the GE Global Research Center Institutio

110 Materials and Methods This prospective study was approved by the independent ethics committees of Kan

111 Materials and Methods The study was approved by the institutional animal care and use co

112 Materials and Methods This study was approved by the institutional animal care and use co

113 Materials and Methods This study was approved by the Institutional Animal Care and Use Co

114 The study was approved by the Institutional Animal Care and Use Co

115 Materials and Methods The animal protocol was approved by the institutional animal care and use co

116 Materials and Methods This prospective study was approved by the Institutional Animal Care and Use Co

117 This study was approved by the institutional animal care committee.

118 terials and Methods This retrospective study was approved by the institutional board review; written

119 ed from all patients, and the study protocol was approved by the institutional committee on human res

120 This retrospective study was approved by the institutional ethics committee, and

121 This prospective study was approved by the institutional ethics committee, and

122 terials and Methods This retrospective study was approved by the institutional ethics committee.

123 MATERIALS AND METHODS This prospective study was approved by the institutional ethics committee; info

124 c resonance (MR) imaging substudy; the study was approved by the institutional research board, and wr

125 Materials and Methods This research was approved by the institutional review board (IRB) and

126 Materials and Methods This study was approved by the institutional review board and all p

127 This study was approved by the institutional review board and by na

128 rials and Methods This cross-sectional study was approved by the institutional review board and compl

129 Materials and Methods This study was approved by the institutional review board and compl

130 terials and Methods This retrospective study was approved by the institutional review board and compl

131 Materials and Methods This study was approved by the institutional review board and compl

132 This prospective study was approved by the institutional review board and compl

133 This study was approved by the institutional review board and compl

134 The study was approved by the institutional review board and compl

135 This retrospective analysis was approved by the institutional review board and compl

136 hods This single-center, retrospective study was approved by the institutional review board and compl

137 Materials and Methods This study was approved by the institutional review board and compl

138 The research was approved by the institutional review board and confo

139 Methods: This retrospective study was approved by the institutional review board and inclu

140 The study was approved by the institutional review board and is He

141 Materials and Methods The study was approved by the institutional review board and local

142 The study was approved by the institutional review board and patie

143 rials and Methods Work with human stem cells was approved by the institutional review board and the s

144 This prospective single-center cohort study was approved by the institutional review board and was c

145 Materials and Methods The study was approved by the institutional review board and writt

146 This retrospective HIPAA-compliant study was approved by the institutional review board of Duke U

147 ods This HIPAA-compliant retrospective study was approved by the institutional review board of the Un

148 Materials and Methods The study was approved by the Institutional Review Board of the Un

149 The study was approved by the institutional review board of Thomas

150 terials and Methods This retrospective study was approved by the institutional review board of three

151 This retrospective study was approved by the institutional review board with pati

152 This HIPAA-compliant study was approved by the institutional review board with waiv

153 Materials and Methods This study was approved by the institutional review board, and all

154 The study was approved by the institutional review board, and all

155 This study was approved by the institutional review board, and all

156 Materials and Methods This study was approved by the institutional review board, and all

157 terials and Methods This retrospective study was approved by the institutional review board, and info

158 This retrospective study was approved by the institutional review board, and info

159 terials and Methods This retrospective study was approved by the institutional review board, and the

160 This single-center retrospective study was approved by the institutional review board, and the

161 ods This HIPAA-compliant retrospective study was approved by the institutional review board, and the

162 ods This HIPAA-compliant retrospective study was approved by the institutional review board, and the

163 This retrospective study was approved by the institutional review board, and the

164 This HIPAA-compliant study was approved by the institutional review board, and the

165 This HIPAA-compliant retrospective study was approved by the institutional review board, and the

166 This retrospective study was approved by the institutional review board, and writ

167 This study was approved by the institutional review board, and writ

168 SHIP was approved by the institutional review board, and writ

169 Materials and Methods This study was approved by the institutional review board, and writ

170 terials and Methods This retrospective study was approved by the institutional review board, which wa

171 t retrospective, single-institution analysis was approved by the institutional review board, with wai

172 Materials and Methods This study was approved by the institutional review board.

173 thods This prospective HIPAA-compliant study was approved by the institutional review board.

174 ective, single-center, HIPAA-compliant study was approved by the institutional review board.

175 compliant, single-center retrospective study was approved by the institutional review board.

176 Methods This prospective case-control study was approved by the institutional review board.

177 Materials and Methods This prospective study was approved by the institutional review board.

178 s This prospective and HIPAA-compliant study was approved by the institutional review board.

179 center retrospective study and meta-analysis was approved by the institutional review board.

180 This HIPAA-compliant retrospective study was approved by the institutional review board.

181 This study was approved by the institutional review board.

182 This retrospective study was approved by the institutional review board.

183 rials and Methods This HIPAA-compliant study was approved by the institutional review board.

184 terials and Methods This retrospective study was approved by the institutional review board.

185 ingle-institution retrospective cohort study was approved by the institutional review board.

186 Materials and Methods The study was approved by the institutional review board.

187 terials and Methods This retrospective study was approved by the institutional review board; informed

188 thods This prospective cross-sectional study was approved by the institutional review board; informed

189 ods This HIPAA-compliant retrospective study was approved by the institutional review board; the requ

190 Materials and Methods This prospective study was approved by the institutional review boards and comp

191 Materials and Methods The study protocol was approved by the institutional review boards and was

192 The HIPAA-compliant protocol was approved by the institutional review boards of all p

193 The study was approved by the institutional review boards of the c

194 als and Methods The HIPAA-compliant protocol was approved by the institutional review boards of the p

195 thods This prospective cross-sectional study was approved by the institutional review boards, and all

196 thods This HIPAA-compliant prospective study was approved by the institutional review boards, and wri

197 nd Methods For this prospective study, which was approved by the internal review board, a total of 12

198 EGISTRATIONPhase I/II protocol (NCT03480152) was approved by the IRB committee of the NIH and the FDA

199 The study was approved by the Johns Hopkins institutional review b

200 The trial protocol was approved by the Local Ethical Committee of the Kirik

201 Materials and Methods This study was approved by the local ethical committee, and written

202 This study was approved by the local ethical committee, and written

203 Materials and Methods This prospective study was approved by the local ethical committee.

204 This study was approved by the local ethical committees on human st

205 This study was approved by the local ethical committees on human st

206 rospective cohort study were included, which was approved by the local ethics board and written infor

207 nance (MR) imaging studies from 2008 to 2015 was approved by the local ethics board.

208 and Methods Retrospective evaluation of data was approved by the local ethics committee and informed

209 Materials and Methods The study was approved by the local ethics committee and the local

210 Methods This prospective case-control study was approved by the local ethics committee and the resea

211 terials and Methods This retrospective study was approved by the local ethics committee and written i

212 Materials and Methods This study was approved by the local ethics committee at all partic

213 Retrospective data evaluation was approved by the local ethics committee of the Univer

214 Materials and Methods The study was approved by the local Ethics Committee, and all pati

215 Materials and Methods The study was approved by the local ethics committee, and all subj

216 The study was approved by the local ethics committee, and all subj

217 ls and Methods Retrospective data evaluation was approved by the local ethics committee, and the requ

218 Materials and Methods This in vivo study was approved by the local ethics committee, and written

219 The study was approved by the local ethics committee, and written

220 This retrospective HIPAA-compliant study was approved by the local ethics committee, and written

221 Materials and Methods The study protocol was approved by the local ethics committee.

222 omplied with the Declaration of Helsinki and was approved by the local ethics committee.

223 nterpretation of prospectively acquired data was approved by the local ethics committee.

224 Materials and Methods The study was approved by the local ethics committee.

225 Materials and Methods This prospective study was approved by the local ethics committees, and written

226 The protocol was approved by the local institutional review board and

227 This study was approved by the local institutional review board and

228 This prospective study was approved by the local institutional review board, an

229 Methods This retrospective comparative study was approved by the local institutional review board.

230 This retrospective study was approved by the local institutional review board; in

231 Materials and Methods This study was approved by the local medical ethical committees of

232 Materials and Methods The study was approved by the local research ethics committee, and

233 ials and Methods This retrospective analysis was approved by the local research ethics committee.

234 This study was approved by the local research ethics committee.

235 gave written informed consent and the study was approved by the local research ethics committee.

236 aterials and Methods This case-control study was approved by the local research ethics committee.

237 Materials and Methods The study was approved by the local review board (NL42888.029.13).

238 Our research was approved by the McGill institutional review board (A

239 The study was approved by the National Research Ethical Committee,

240 Materials and Methods This study was approved by the national research ethics committee a

241 The study was approved by the national research ethics committee,

242 METHODS AND This study was approved by the National Research Ethics Service Com

243 Materials and Methods The study was approved by the National Research Ethics Service Com

244 This study was approved by the Partners in Health/Zanmi Lasante Res

245 The study was approved by the regional ethics committee, and all p

246 rials and Methods This HIPAA-compliant study was approved by the regional ethics committee.

247 id Capture 2 human papillomavirus (HPV) test was approved by the U.S. Food and Drug Administration (F

248 Left atrial appendage closure (LAAC) was approved by the U.S. Food and Drug Administration (F

249 been successful since (177)Lu DOTATATE PRRT was approved by the U.S. Food and Drug Administration.

250 -adjusted PTH reference intervals. The study was approved by the UK Ministry of Defence research ethi

251 d written informed consent, and the protocol was approved by the university institutional review boar

252 The study was approved by the University IRB.

253 This study was approved by the University of Otago Human Ethics Com

254 This study was approved by the University of Toronto Research Ethic

255 Amiodarone is an anti-arrhythmic drug that was approved by the US Food and Drug Administration (FDA

256 uzumab, trastuzumab, and hyaluronidase-zzxf) was approved by the US Food and Drug Administration (FDA

257 ranscatheter aortic valve replacement (TAVR) was approved by the US Food and Drug Administration for

258 Recently, the first agent was approved by the US Food and Drug Administration for

259 ant tissue plasminogen activator (alteplase) was approved by the US Food and Drug Administration in 1

260 Obeticholic acid was approved by the US Food and Drug Administration in 2

261 The study was approved by the Walter Reed National Military Medica

262 This study was approved by the Walter Reed National Military Medica

263 oversight committee, and animal experiments were approved by the administrative panel on laboratory

264 Materials and Methods All animal experiments were approved by the animal care and use committee and a

265 Materials and Methods All procedures were approved by the Animal Care and Use Committee and c

266 All protocols were approved by the Animal Care Committee in accordance

267 (broth, 1 to 4 mug/ml; agar, 1 to 8 mug/ml) were approved by the Clinical and Laboratory Standards I

268 Quality control ranges were approved by the CLSI in 2017 (broth microdilution M

269 disk diffusion (30/20-mug disk) test methods were approved by the CLSI Subcommittee on Antimicrobial

270 and MIC QC ranges established in this study were approved by the CLSI Subcommittee on Antimicrobial

271 n 2007 and 2020, 33 biosimilars for oncology were approved by the European Medicines Agency (EMA), 16

272 All biological mesh devices were approved by the FDA based on substantial equivalenc

273 NDA 212642 for UCLA and NDA 212643 for UCSF) were approved by the Food and Drug Administration as the

274 Animal studies were approved by the Institutional Administrative Panel

275 Materials and Methods All studies were approved by the institutional animal care and use c

276 Materials and Methods Experiments were approved by the institutional animal care and use c

277 Materials and Methods Animal experiments were approved by the institutional animal care and use c

278 Animal model studies were approved by the institutional Animal Care and Use C

279 All procedures were approved by the institutional animal care and use c

280 Materials and Methods All animal procedures were approved by the institutional Animal Care and Use C

281 Materials and Methods All animal studies were approved by the institutional animal care and use c

282 The procedures were approved by the Institutional Animal Care and Use C

283 Materials and Methods All experiments were approved by the institutional animal care and use c

284 Materials and Methods The procedures were approved by the institutional animal care committee

285 e II protocols (NCT01498484 and NCT00002663) were approved by the Institutional Review Board at Memor

286 The animal studies were approved by the local animal ethics committee.

287 Materials and Methods The animal experiments were approved by the local ethics committee.

288 Materials and Methods All experiments were approved by the local institutional review board an

289 Materials and Methods Protocols were approved by the office of biologic safety and insti

290 rence to the Swiss Animal Protection law and were approved by the regional veterinary office.

291 et doses of 25 mg or 35 mg once daily, which were approved by the SRAs for the children's weight band

292 Eight new antibiotics were approved by the U.S. Food and Drug Administration (

293 Materials and Methods All rat experiments were approved by the University of Washington Institutio

294 For oncology drugs that were approved by the US Food and Drug Administration (FD

295 4 patented, injectable anticancer drugs that were approved by the US Food and Drug Administration bet

296 h initial indications for adult cancers that were approved by the US Food and Drug Administration bet

297 Romidepsin and pralatrexate were approved by the US Food and Drug Administration for

298 Materials and Methods All procedures were approved by the Weizmann Institutional Animal Care

299 onucleotide-based drug (nusinersen/Spinraza) was approved by US Food and Drug Administration (FDA) in

300 as obtained for all procedures and the study was approved by Western University's Health Sciences Res